Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106

We have established variants of DLD‐1 human colon carcinoma and HT‐1080 human fibrosarcoma cells resistant to the new anticancer ribo‐nucleosides, 1‐(3‐C‐ethynyl‐β‐D‐ribo‐pentofuranosyl)‐cytosine (ECyd, TAS‐106) and 1‐(3‐C‐ethynyl‐p‐D‐ribo‐pentofuranosyl)uracil (EUrd). Both variants were shown to ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimamoto, Yuji, Kazuno, Hiromi, Murakami, Yuko, Azuma, Atsushi, Koizumi, Katsuhisa, Matsuda, Akira, Sasaki, Takuma, Fukushima, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2002
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927010/
https://www.ncbi.nlm.nih.gov/pubmed/11985795
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01276.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927010/
https://www.ncbi.nlm.nih.gov/pubmed/11985795
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01276.x

Ejemplares similares